Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhong injection hospital registry study
ChiCTR-ONC-13003230Phase 4Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jun 2013
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of danhong injection in brain infarction, coronary arteriosclerosis and angina pectoris, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: 14-day outcome in cerebral infarction, 3-6 month outcome in cerebral infarction and 2 more. Started Jun 2013; status: completed.
02
Drugs
danhong injection
03
Conditions
brain infarctioncoronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on ChiCTR-ONC-13003230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003230.